Expression profile of CTC and corresponding tumors in primary breast cancer patients
http://www.abstract.asco.org/AbstView_65_33299.html
"Conclusions: Since the expression profile between CTC and the primary tumor differs, the consequence for the selection of adjuvant treatment targeting minimal residual disease has to be further evaluated in clinical trials." Hopeful |
All times are GMT -7. The time now is 07:33 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021